JP2018501258A5 - - Google Patents

Download PDF

Info

Publication number
JP2018501258A5
JP2018501258A5 JP2017533485A JP2017533485A JP2018501258A5 JP 2018501258 A5 JP2018501258 A5 JP 2018501258A5 JP 2017533485 A JP2017533485 A JP 2017533485A JP 2017533485 A JP2017533485 A JP 2017533485A JP 2018501258 A5 JP2018501258 A5 JP 2018501258A5
Authority
JP
Japan
Prior art keywords
influenza
polypeptide
recombinant
immunogenic composition
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018501258A (ja
JP6764408B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/066882 external-priority patent/WO2016100922A1/en
Publication of JP2018501258A publication Critical patent/JP2018501258A/ja
Publication of JP2018501258A5 publication Critical patent/JP2018501258A5/ja
Application granted granted Critical
Publication of JP6764408B2 publication Critical patent/JP6764408B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533485A 2014-12-19 2015-12-18 Ｈ１ｎ１インフルエンザに対するコンピュータ最適化広反応性抗原の相乗的併用投与 Expired - Fee Related JP6764408B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462094772P 2014-12-19 2014-12-19
US62/094,772 2014-12-19
PCT/US2015/066882 WO2016100922A1 (en) 2014-12-19 2015-12-18 Synergistic co-administration of computationally optimized broadly reactive antigens for h1n1 influenza

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020131336A Division JP2020186252A (ja) 2014-12-19 2020-08-03 Ｈ１ｎ１インフルエンザに対するコンピュータ最適化広反応性抗原の相乗的併用投与

Publications (3)

Publication Number Publication Date
JP2018501258A JP2018501258A (ja) 2018-01-18
JP2018501258A5 true JP2018501258A5 (enExample) 2019-01-31
JP6764408B2 JP6764408B2 (ja) 2020-09-30

Family

ID=56127736

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017533485A Expired - Fee Related JP6764408B2 (ja) 2014-12-19 2015-12-18 Ｈ１ｎ１インフルエンザに対するコンピュータ最適化広反応性抗原の相乗的併用投与
JP2020131336A Pending JP2020186252A (ja) 2014-12-19 2020-08-03 Ｈ１ｎ１インフルエンザに対するコンピュータ最適化広反応性抗原の相乗的併用投与

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020131336A Pending JP2020186252A (ja) 2014-12-19 2020-08-03 Ｈ１ｎ１インフルエンザに対するコンピュータ最適化広反応性抗原の相乗的併用投与

Country Status (7)

Country Link
US (2) US10220086B2 (enExample)
EP (1) EP3233116A4 (enExample)
JP (2) JP6764408B2 (enExample)
CN (1) CN107530417A (enExample)
AU (1) AU2015364253B2 (enExample)
CA (1) CA2970158A1 (enExample)
WO (1) WO2016100922A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107530417A (zh) * 2014-12-19 2018-01-02 俄勒冈健康与科学大学 H1n1流感的计算优化的广泛反应性抗原的协同共同给药
WO2019086463A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
WO2019108319A1 (en) * 2017-12-01 2019-06-06 Kemin Industries, Inc. Compositions containing euglena gracilis for viral protection and related methods
WO2019191261A1 (en) * 2018-03-28 2019-10-03 Sanofi Pasteur Inc. Methods of generating broadly protective vaccine compositions comprising neuraminidase
WO2020092207A1 (en) * 2018-10-28 2020-05-07 University Of Georgia Research Foundation Broadly reactive immunogens of influenza virus, compositions, and methods of use thereof
CN117693359A (zh) * 2021-06-10 2024-03-12 乔治亚大学研究基金会股份有限公司 作为免疫原的广泛反应性病毒抗原、其组合物和使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100221284A1 (en) * 2001-05-30 2010-09-02 Saech-Sisches Serumwerk Dresden Novel vaccine composition
WO2014124423A1 (en) * 2013-02-11 2014-08-14 Smith Gale E Combination vaccine for respiratory syncytial virus and influenza
KR20120027276A (ko) * 2009-04-27 2012-03-21 노파르티스 아게 인플루엔자를 예방하기 위한 면역증강된 백신
AU2013240365B2 (en) * 2012-03-30 2017-03-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computationally optimized broadly reactive antigens for H5N1 and H1N1 influenza viruses
SG11201503989PA (en) * 2012-11-27 2015-06-29 Univ Pittsburgh Computationally optimized broadly reactive antigens for h1n1 influenza
CN107530417A (zh) * 2014-12-19 2018-01-02 俄勒冈健康与科学大学 H1n1流感的计算优化的广泛反应性抗原的协同共同给药
EP3307761A4 (en) * 2015-06-09 2019-01-16 Sanofi Pasteur Inc. PROCESS FOR OPTIMIZING NUCLEOTIDE SEQUENCES COPING MANIPULATED INFLUENZA PROTEINS
WO2017053413A1 (en) * 2015-09-21 2017-03-30 Oregon Health & Science University Vaccines intelligently produced by epitope recombination (viper) for influenza

Similar Documents

Publication Publication Date Title
JP2018501258A5 (enExample)
JP2015186478A5 (enExample)
JP2016506416A5 (enExample)
JP2009511084A5 (enExample)
JP2016199557A5 (enExample)
RU2015132962A (ru) Иммуногенные композиции на основе вируса гриппа и их применение
WO2019246363A8 (en) Mosaic influenza virus hemagglutinin polypeptides and uses thereof
JP2016520530A5 (enExample)
JP2015214545A5 (enExample)
JP2018504412A5 (enExample)
WO2009026397A3 (en) Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
ES2673556T3 (es) Vacunas para el VHS-2
JP2014502156A5 (enExample)
IL276210B2 (en) Mers-cov vaccine
JP2010500399A5 (enExample)
JP2019530462A5 (enExample)
JP2015522540A5 (enExample)
JP2016534034A5 (enExample)
PE20142330A1 (es) Vacuna de peptido ch3 de ige
JP2013518052A5 (enExample)
JP2015506705A5 (enExample)
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
JP2010508030A5 (enExample)
WO2015195218A8 (en) Polyvalent influenza virus-like particles (vlps) and use as vaccines
AR108781A1 (es) Aumento de la inmunogenicidad del péptido l2 de virus de papiloma humano (hpv)